TABLE 2.
Outcome |
Treatment type* |
P | |
---|---|---|---|
APC (n=14) | AFR (n=11) | ||
Response, % | 78.5 | 27.2 | 0.017 |
Single session responders, % | 63.6 | 33.3 | NS |
Adverse effects, % | 33.3 | 81.8 | 0.001 |
Mean post-treatment hemoglobin level, g/L | 125.5 | 120.1 | NS |
*Three patients received both APC and AFR treatment. NS Not significant